California-based company Zogenix (NASDAQ:ZGNX) observed the drug fenfluramine, which had problematic side effects in obesity, and demonstrated it could work to prevent seizures. At a time when GW Pharmaceuticals (GWPH) and Insys Therapeutics (INSY) were advancing cannabidiol (CBD)-based drugs to […]
GeoInvesting June 2018 Highlights What We’re Tracking Stocks we monitor very closely We recently just took a position in a medical device technology company that offers more liquidity than the average microcap we usually bring to our members. We are betting […]
GeoInvesting May 2018 Highlights What We’re Tracking Stocks we monitor very closely Usually, in this section of the newsletter, we only note one stock that we’re watching. This month, it is a whole group of stocks that we have conveniently […]
On May 18, 2018, Bryan McLaren, CEO of Zoned Properties Inc. (OOTQX:ZDPY) spoke with GeoInvesting analyst Christopher Irons for an Executive Casts interview that covered an array of topics, most notably one in which Mr. McLaren broke down the decision […]
GeoInvesting April 2018 Highlights What We’re Tracking Stocks we monitor very closely We recently started watching shares of a company that has performed a warrant restructuring and is in the process of settling some of its outstanding legal liabilities. The […]
Introduction By Maj Soueidan, Co-Founder GeoInvesting Marty Whitman holds a special place in the hearts of many deep value investors. As you may know, Marty Whitman passed away on April 16, 2018, but leaves behind a legacy that includes market […]
I make a case for gold at Kase Learning’s “The Art of Short Selling” event, touching on how the government largely controls the direction of the market, how economists got it wrong, and why you should keep an open mind to […]
GeoInvesting March 2018 Highlights What We’re Tracking Stocks we monitor very closely We have recently been watching an early-stage turnaround story in a high-growth industry, where the company is only trading at about 6x our forward EPS estimates. Our recent […]